TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
NOVT

Novanta Inc

Technology · Scientific & Technical Instruments

141.30$ +3.6% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Novanta Inc (NOVT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,140 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NOVT
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
417 426 535 550 722 727 734 742 759 720 753 783 858 870 842 861 858 865 852 878 1,210 1,228 1,206 1,206 1,208 1,241 1,226 1,233 1,194 1,226 1,411 1,399 1,419 1,389 1,385 1,511 1,506 1,807 1,799 2,140
196 199 230 246 280 288 298 296 313 282 287 285 297 305 297 310 303 304 309 336 353 374 375 399 408 421 405 414 391 415 429 425 437 434 434 462 468 783 787 1,124
65 68 80 89 92 100 111 107 112 82 74 66 61 79 74 97 107 125 114 134 102 117 99 100 85 100 83 91 76 105 94 98 93 114 106 110 89 381 389 719
65 68 80 89 92 100 111 107 112 82 74 66 61 79 74 97 107 125 114 134 102 117 99 100 85 100 83 91 76 105 94 98 93 114 106 110 89 381 389 719
66 64 70 69 83 81 77 77 89 84 89 89 99 91 90 88 82 75 90 90 112 116 124 130 145 138 141 145 143 139 151 145 165 151 164 161 171 185 174 179
60 60 71 77 89 91 99 96 99 105 107 113 119 117 112 107 102 93 90 95 119 126 139 154 163 168 167 163 154 149 161 160 154 145 145 168 180 188 193 193
35 35 37 37 60 62 62 65 66 65 65 65 76 78 75 75 76 79 78 114 86 136 90 88 95 103 104 147 – – – – – – – – – – – –
108 108 150 152 208 211 214 218 220 218 218 230 269 275 269 274 280 286 282 283 493 480 476 466 465 479 483 483 478 485 590 587 594 584 589 649 648 647 643 642
61 62 104 101 158 155 152 155 151 143 137 153 168 166 155 152 150 149 139 133 231 221 208 193 179 176 169 161 151 145 215 207 198 186 178 204 193 181 170 160
160 167 219 218 376 368 360 366 400 351 373 397 455 453 429 429 406 388 376 385 710 707 671 674 665 664 628 607 549 553 729 697 677 643 616 710 704 493 488 523
67 70 78 83 96 98 92 93 109 104 101 99 125 135 135 129 134 114 117 127 188 184 183 198 158 165 142 136 138 139 151 153 157 168 170 182 187 212 221 246
7.4 7.4 7.4 7.4 9.1 9.1 9.1 9.1 9.1 4.5 7.4 5.2 5.1 10 19 19 20 21 12 12 13 13 13 13 13 13 13 13 14 14 15 15 16 15 16 16 17 49 50 51
28 32 34 38 40 40 42 43 48 51 51 50 47 53 48 46 41 43 52 54 65 69 72 77 80 75 66 65 64 57 71 71 69 77 83 89 100 95 96 97
72 71 111 104 234 226 224 228 247 203 198 215 228 215 207 212 188 195 186 187 442 429 413 403 438 431 419 404 348 349 509 477 453 412 385 454 446 213 201 188
257 259 294 305 309 312 319 324 360 368 380 386 403 417 413 432 451 477 476 493 500 521 535 532 542 578 598 626 645 673 682 702 742 746 770 801 801 1,314 1,311 1,616
-175 -168 -133 -128 -128 -128 -123 -112 -91 -79 -67 -56 -48 -38 -26 -15 -6.5 6.2 18 29 43 57 75 93 115 131 149 170 191 203 218 232 251 268 289 293 304 321 342 355
35 35 35 35 35 35 35 35 35 35 35 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 36 39 41 41

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?